Go here to read the rest:
CorMedix to Participate at the JMP Securities Life Sciences Conference
Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress
AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center
ExCellThera announces submission of Drug Master File for UM171
Go here to see the original:
ExCellThera announces submission of Drug Master File for UM171
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
Read the original here:
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
Neurona Therapeutics to Present Preclinical Data Supporting Regenerative Cell Therapy, NRTX-1001, in Clinical Development for Chronic Focal Epilepsy,…
Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention
Vaxart Announces Adjournment of Annual Meeting of Stockholders
See the rest here:
Vaxart Announces Adjournment of Annual Meeting of Stockholders
Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms
See the original post here:
Healthy Extracts New Clinical Study Highlights UBN RELIEF Naturally Alleviates Migraine Symptoms
MacroGenics to Participate in Upcoming Investor Conference
Go here to see the original:
MacroGenics to Participate in Upcoming Investor Conference
Genmab to Participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference
Go here to see the original:
Genmab to Participate in a Fireside Chat at the Goldman Sachs 43rd Annual Global Healthcare Conference
Iovance Biotherapeutics to Present at Upcoming Conferences
Original post:
Iovance Biotherapeutics to Present at Upcoming Conferences